Nasdaq nstg.

NanoString Technologies, Inc. (NASDAQ:NSTG) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ETCompany Participants. Doug Farrell – Vice President, Investor Relations and Corporate ...Nov 7, 2023 · Hedge Funds Are Piling Into NanoString Technologies Inc (NSTG) Top 5 Stock Picks of Efrem Kamen's Pura Vida Investments NanoString Technologies, Inc. (NASDAQ:NSTG) Q1 2023 Earnings Call Transcript ... Fintel reports that on November 20, 2023, TD Cowen downgraded their outlook for Nanostring Technologies (NASDAQ:NSTG) from Outperform to Market Perform. Analyst Price Forecast Suggests 1,436.84% ...SEATTLE and DANVERS, Mass., March 10, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic ...

Nanostring Technologies Inc (NASDAQ: NSTG)’s stock price has increased by 10.67 compared to its previous closing price of 0.52. However, the company has seen a -56.41% decrease in its stock price over the last five trading sessions. Business Wire reported 2023-11-09 that SEATTLE–(BUSINESS WIRE)–NanoString to present at November conferences. Is It Worth Investing in Nanostring […]Find the latest historical data for NanoString Technologies, Inc. Common Stock (NSTG) at Nasdaq.com.

SEATTLE and CAMBRIDGE, UK, April 01, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic ...

November 19, 2023 — 08:21 pm EST. Written by RTTNews.com for RTTNews ->. (RTTNews) - NanoString Technologies Inc. (NSTG) said it respectfully disagreed with the verdict of the jury in the U.S ...Fintel reports that on October 12, 2023, UBS maintained coverage of Nanostring Technologies (NASDAQ:NSTG) with a Buy recommendation.. Analyst Price Forecast Suggests 768.49% Upside. As of October ...NanoString Technologies Inc (NASDAQ:NSTG) is not the most popular stock in this group but hedge fund interest is still above average. Our overall hedge fund sentiment score for NSTG is 66.9.NanoString Technologies, Inc. Common Stock (NSTG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. SEATTLE, March 27, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research. The company's technology enables a wide ...

SEATTLE, Sept. 18, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...

November 19, 2023 — 08:21 pm EST. Written by RTTNews.com for RTTNews ->. (RTTNews) - NanoString Technologies Inc. (NSTG) said it respectfully disagreed with the verdict of the jury in the U.S ...View NanoString Technologies, Inc NSTG investment & stock information. Get the latest NanoString Technologies, Inc NSTG detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Within the last quarter, NanoString Technologies (NASDAQ:NSTG) has observed the following analyst ratings: According to 5 analyst offering 12-month price targets in the last 3 months, NanoString ...Nov 27, 2023 · Fintel reports that on November 27, 2023, JP Morgan downgraded their outlook for Nanostring Technologies (NASDAQ:NSTG) from Overweight to Neutral. Analyst Price Forecast Suggests 593.19% Upside As ... EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission. Find the latest Financials data for NanoString Technologies, Inc. Common Stock (NSTG) at Nasdaq.com. Within the last quarter, NanoString Technologies (NASDAQ:NSTG) has observed the following analyst ratings: According to 5 analyst offering 12-month price targets in the last 3 months, NanoString ...

NanoString Technologies, Inc. (NASDAQ:NSTG) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ETCompany Participants. Doug Farrell – Vice President, Investor Relations and Corporate ...The latest NanoString Technologies stock prices, stock quotes, news, and NSTG history to help you invest and trade ... The Dow traded up 0.34% to 35,064.42 …NanoString ( NASDAQ: NSTG) lost half of its market value on Monday after a legal setback in Delaware over a patent dispute prompted the life sciences company to withdraw its guidance. On Friday ...NanoString Technologies, Inc. (NSTG.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock NanoString Technologies, ...NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research. The company's technology enables a wide variety of basic research and ...NanoString Technologies last posted its earnings results on November 6th, 2023. The biotechnology company reported ($0.78) earnings per share for the quarter, missing analysts' consensus estimates of ($0.53) by $0.25. The company had revenue of $48.09 million for the quarter, compared to analyst estimates of $46.05 million.Fintel reports that on November 21, 2023, Baird downgraded their outlook for Nanostring Technologies (NASDAQ:NSTG) from Outperform to Neutral . Analyst Price Forecast Suggests 1,436.84% Upside As ...

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported prelimi

The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.NanoString Technologies (NASDAQ:NSTG) Q4 2013 Earnings Conference Call February 26, 2014 4:30 PM ETExecutives. Lynn Pieper - Managing Director, Westwicke Partners LLC. Bradley Gray - President and ...Jul 10, 2023 · SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the second quarter ended June 30, 2023. JP Morgan has downgraded NanoString ( NASDAQ: NSTG) to neutral due to limited near-term visibility amid ongoing patent litigation. The investment bank noted that NanoString is embroiled in ongoing ...SEATTLE & MUNICH--(BUSINESS WIRE)-- NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today responded to the Regional Court of Munich’s recent decision finding that NanoString’s CosMx Spatial Molecular Imager, when used to detect RNA targets, infringes the German part of the European patent 2794928B1.SEATTLE, Feb. 29, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...NanoString Technologies Inc (NASDAQ:NSTG) is not the most popular stock in this group but hedge fund interest is still above average. Our overall hedge fund sentiment score for NSTG is 66.9.

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced an update to the technology roadmap for the CosMx™ Spatial Molecular Imager (SMI) that will be presented at the 2023 Advances in Genome Biology and …

Nov 11, 2023 · Based on these gigs, the overall price performance for the year is -81.57%. The short interest in Nanostring Technologies Inc (NASDAQ:NSTG) is 13.57 million shares and it means that shorts have 11.14 day (s) to cover. The consensus price target of analysts on Wall Street is $6.64, which implies an increase of 83.73% to the stock’s current value.

"NanoString Technologies, Inc. (NASDAQ:NSTG): NSTG is a leader in spatial biology, offering a platform of products that help researchers map biology down to a single-cell. Since our purchase of ...SEATTLE and CAMBRIDGE, UK, April 01, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic ...NanoString (NASDAQ:NSTG) lost half of its market value on Monday after a legal setback in Delaware over a patent dispute prompted the life sciences company to withdraw its guidance.On Friday, 10x ...NSTG) stock’s latest price update. Nanostring Technologies Inc (NASDAQ: NSTG) has seen a decline in its stock price by -3.76 in relation to its previous close of 1.33. However, the company has experienced a 18.52% gain in its stock price over the last five trading sessions.Find the latest NanoString Technologies Inc (NSTG) discussion and analysis from iHub's community of investors.NanoString Technologies, Inc. (NASDAQ:NSTG) Q3 2023 Earnings Call Transcript Published on November 7, 2023 at 10:52 am by Insider Monkey Transcripts in News , Transcripts Share Tweet EmailFounded in 2003, NanoString’s (NASDAQ:NSTG) nCounter technology is a variant on the DNA microarray. As of the first quarter of 2022, Kamen’s Pura Vida Investments owns more than 1.2 million ...Barron's 400. Market Data. NSTG. U.S.: Nasdaq. Average price target from. 0.4710 - 13.2000. 115.14K (6.09% of Avg) Pacific Biosciences of California Inc. Agilent …SEATTLE, February 23, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management ...21 Nov 2023 ... Baird downgraded NanoString (NASDAQ:NSTG) from Buy to Neutral on Tuesday after the life sciences company withdrew its guidance following a ...

SEATTLE, January 19, 2023--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a public release of new ...Nov 30, 2023 · NASDAQ NSTG opened at $0.50 on Thursday. The company has a market cap of $24.26 million, a P/E ratio of -0.14 and a beta of 1.67. NanoString Technologies has a 1 year low of $0.47 and a 1 year high of $13.20. The company has a current ratio of 2.73, a quick ratio of 2.02 and a debt-to-equity ratio of 16.67. The company has a fifty day simple ... NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the …Nov 28, 2023 · NanoString Technologies has a one year low of $0.47 and a one year high of $13.20. The firm has a market capitalization of $26.74 million, a PE ratio of -0.16 and a beta of 1.67. The company has a debt-to-equity ratio of 16.67, a quick ratio of 2.02 and a current ratio of 2.73. NanoString Technologies ( NASDAQ:NSTG – Get Free Report) last ... Instagram:https://instagram. tpg valuese stokfidelity stock price historyameritrade options NanoString Technologies Inc. NSTG (U.S.: Nasdaq) NanoString Technologies Inc. View All companies. AT CLOSE 4:00 PM EST 12/01/23.NanoString Technologies, Inc. Common Stock (NSTG) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. efsh stocktwitsis macy's stock a buy SEATTLE and CAMBRIDGE, UK, April 01, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic ...SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced it will host its fifth annual ... top mover NanoString Technologies (NSTG) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $0.86 per share a year ago.Nov 29, 2023 · NanoString Technologies (NSTG) Scheduled to Post Earnings on Thursday marketbeat.com - July 27 at 2:27 AM: NanoString Technologies (NASDAQ:NSTG) Cut to "Sell" at StockNews.com marketbeat.com - July 20 at 1:19 AM: NanoString Technologies, Inc. (NASDAQ:NSTG) Receives Average Rating of "Moderate Buy" from Analysts marketbeat.com - July 16 at 4:40 AM NanoString ( NASDAQ: NSTG) lost half of its market value on Monday after a legal setback in Delaware over a patent dispute prompted the life sciences company to withdraw its guidance. On Friday ...